SARS-CoV-2 Infection and Lung Regeneration-Reference-Cited by-同舟云学术

SARS-CoV-2 Infection and Lung Regeneration

Published:2022-04-20 Issue:2 Volume:35 Page:
ISSN:0893-8512
Container-title:Clinical Microbiology Reviews
language:en
Short-container-title:Clin Microbiol Rev

Author:

Zhao Fuxiaonan¹,Ma Qingwen¹,Yue Qing¹,Chen Huaiyong¹²³⁴^ORCID

Affiliation:

1. Department of Basic Medicine, Haihe Clinical School, Tianjin Medical University, Tianjin, China

2. Key Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institute of Respiratory Diseases, Tianjin Haihe Hospital, Tianjin, China

3. Department of Basic Medicine, Haihe Hospital, Tianjin University, Tianjin, China

4. Tianjin Key Laboratory of Lung Regenerative Medicine, Tianjin, China

Abstract

The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced immunopathology whereby the virus enters the host cells by binding to angiotensin-converting enzyme 2 (ACE2). Sophisticated regeneration and repair programs exist in the lungs to replenish injured cell populations.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Tianjin City

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Link

https://journals.asm.org/doi/pdf/10.1128/cmr.00188-21

Reference264 articles.

1. The Airway Epithelium: Soldier in the Fight against Respiratory Viruses

2. The innate immune function of airway epithelial cells in inflammatory lung disease